drugset / Trial / NCT06618651
A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, multi-center, multiple dose Phase I study to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-3821 injection in subjects with advanced solid tumors.
Timeline
- Start
- 2024-11-13
- Primary completion
- 2026-01-01
- Completion
- 2027-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-3821 | Unknown | — | — |
Indications
No indication recorded.